Obesity and metabolic syndrome in childhood;Obesidad y síndrome metabólico en la infancia

Endocrinologia y Nutricion

Volumn 52, Issue 2, 2005, Pages 65-74

  Barrio, Raquel ^a,b   Lopez Capape M ^a   Colino, E ^a   Mustieles, C ^a   Alonso, M ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Adolescence; Cardiovascular risk factors; Childhood; Insulin resistance; Obesity; Type 2 diabetes

Indexed keywords

ACTIVATED PROTEIN C; ADIPONECTIN; APOLIPOPROTEIN A; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLASMINOGEN ACTIVATOR INHIBITOR 1; RESISTIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; URIC ACID;

ADOLESCENCE; BODY MASS; CARDIOVASCULAR RISK; CHILDHOOD DISEASE; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; REVIEW;

EID: 16444383069     PISSN: 15750922     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1575-0922(05)70990-6     Document Type: Article

References (59)

1. Miller J, Rosenbloom A, Silverstein J. Childhood obesity. J Clin Endocrinol Metab. 2004;89:4211-8.
2. Flegal KM, Carroll MD, Ogden CI, Jonson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA. 2002;288:1723-7.
3. Ogden CL, Flegal KM, Carroll MD, Jonson CL. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA. 2002;288:1728-32.
4. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents and adults, 1999-2002. JAMA. 2004;291:2847-50.
5. Thibault H, Rolland-Cachera MF. Prevention strategies of childhood obesity. Arch Pediatr. 2003;10:1100-8.
6. Deckelbaum RJ, Williams CL. Childhood obesity: the health issue. Obes Rev. 2001;9 Suppl 4:S239-43.
7. Kuczmarski RJ, Carroll MD, Flegal KM, Troyano RP. Varying body mass index cut-off points to describe overweight prevalence among US adults: NHANES III (1988 to 1994). Obes Res. 1997;5:542-8.
8. Maffeis C, Moghetti P, Grezzani A, Clementi M, Gaudino R, Tato L. Insulin resistance and the persistence of obesity from childhood into adulthood. J Clin Endocrinol Metab. 2002;87:71-6.
9. Gunnell DJ, Frankel SJ, Nanchahal K, Peters TJ, Davey Smith G. Childhood obesity and adult cardiovascular, mortality: a 57 y follow-up study based on the Boyd Orr cohort. Am J Clin Nutr. 1998;67:1111-8.
10. Livingstone MB, Robson PJ, Wallace JM, McKinley MC. How active are we? Levels of routine physical activity in children and adults. Proc Nutr Soc. 2003;62:681-701.
11. Poulsen P, Vaag A. The impact of genes and pre and postnatal environment on the metabolic syndrome. Evidence from twin studies. Panminerva Med. 2003;45:109-15.
12. Dietz WH, Robinson TN. Use of the body mass index as a measure of overweight in children and adolescent. J Pediatr. 1998;132:191-3.
13. Cole T, Bellizzi M, Flegal K, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ. 2000;320:1240-3.
14. Ten S, Maclaren N. Insulin resistance syndrome in children. J Clin Endocrinol Metab. 2004;89:2526-39.
15. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Throm Vas Biol. 2004;24:E13-8.
16. Ozane SE, Hales CN. Early programming of glucose-insulin metabolism. Trends Endocrinol Metab. 2002;13:368-73.
17. National Cholesterol Education Panel (NCEP) Adult Treatment Panel III (ATP III). JAMA. 2001;285:2486.
18. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents. Findings from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med. 2003;157:821-7.
19. Goran MI, Ball GDC, Cruz ML. Cardiovascular endocrinology 2: obesity and risk of type 2 diabetes and cardiovascular disease in children and adolescents. J Clin Endocrinol Metab. 2003;88:1417-27.
20. Steinberger J. Diagnosis of the metabolic syndrome in children. Curr Opin Lipidol. 2003;14:555-9.
21. Berenson GS, Srinivasan Sr, Wattigney WA, Harsha DW. Obesity and cardiovascular risk in children. Ann NY Acad Sci. 1993;699:93-100.
22. Freedman DS, Dietz W, Srinivasan SR, Berenson GS. The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa Heart Study. Pediatrics. 1999;103:1175-82.
23. Ford ESG. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-9.
24. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350:2362-74.
25. Steinberger J. Insulin resistance and cardiovascular risk in the pediatric patient. Prog Pediatr Cardiol. 2002;12:169-75.
26. McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med. 2003;139:802-9.
27. Reaven GM. Insulin resistance, compensatory hyperinsulinemia, and coronary heart disease syndrome X revisited. En: Jefferson LS, Cherrington AD, editors. Handbook of physiology: Section 7. The Endocrine System. Vol II. The Endocrine Pancreas and Regulation of Metabolism. Oxford: Oxford University Press; 2001. p. 1169-97.
28. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med. 1993;329:1988-92.
29. Zavaroni I, Bonni I, Gasparini P, Barilli AL, Zuccarelli A, DallÁglio E, et al. Hyperinsulinemia in normal population as a predictor of non-insulin-dependent diabetes mellitus, hypertension and coronary heart disease; the Barilla factory revisited. Metabolism. 1999;48:989-94.
30. Ascaso JF, Pardo S, Real JT, Lorente RI, Priego A, Carmena R. Diagnosis insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care. 2003;26:3320-5.
31. Expert Committee on Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes. Diabetes Care. 2003;26:3160-7.
32. Jeppensen F, Hein HO, Suadicani P, Gyntelberg F. Low triglycerides-high density lipoprotein cholesterol and risk ischemic heart disease. Arch Intern Med. 2001;161:361-6.
33. Amiel SA, Sherwin RS, Simonson DC, Lauritano AA, Tamborlane WV. Impaired insulin action in puberty: a contributing factors to poor glycemic control in adolescents with diabetes. N Engl J Med. 1986;315:215-9.
34. Cruz ML, Weigensberg M, Huang T, Ball G, Shabi G, Goran M. The metabolic syndrome in overweight hispanic youth and the role of insulin sensitivity. J Clin Endocrinol Metab. 2004;89:108-13.
35. Arslanian S. Type 2 diabetes in children: clinical aspects and risk factors. Horm Res. 2002;57 Supl 1:19-28.
36. Lipton R, Keenan H, Onyemere KU, Freels S. Incidence and onset features of diabetes in African-American and Latino children in Chicago, 1985-1994. Diabetes Metab Res Rev. 2002;18:135-42.
37. Bonadonna R, Groop L, Kraemer N, DeFronzo RA. Obesity and insulin resistance in man: a dose response study. Metabolism. 1990;39:452-9.
38. Pinhas-Hamiel O, Dolan LM, Daniels SR, Standiford D, Khoury PR, Zeitler P. Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. J Pediatr. 1996;128:608-15.
39. Sinha R, Fish G, Teague B, Tamborlane WV, Banyas B, Allen K, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med. 2002;346:802-10.
40. Paulsen EP, Richenderfer L, Ginsberg-Fellner F. Plasma glucose, free fatty acids and immunoreactive insulin in sixty-six obese children. Diabetes. 1968;17:261-9.
41. Srinivasan SR, Frontón MG, Berenson GS. Longitudinal changes in risk variables of insulin resistance syndrome from childhood to young adulthood in offspring of parents with type 2 diabetes: the Begolusa Heart study. Metabolism. 2003;52:443-50.
42. Goran MI, Bergman RN, Ávila Q, Watkins M, Ball G, Shaibi GQ, et al. Impaired glucose tolerance and reduced b-cell function in overweight latino children with a positive family history for type 2 diabetes. J Clin Endocrinol Metab. 2004;89:207-12.
43. Davis PH, Dawson JD, Riley WA, Lauer RM. Carotid intimal-medial thickness is related to cardiovascular risk factors measured fron childohood through middle age: the Muscatin Study. Circulation. 2001;104:2815-9.
44. Berenson GS, Srinivasan Sr, Bao W, Newman WP 3rd, Tracy RE, Watligney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. N Engl J Med. 1998;338:1650-6.
45. Willians CL, Hayman LL, Daniels SR, Robinson TN, Steinberger J, Paridon S, et al. Cardiovascular health in childhood: a statement for health professionals from the Committee on Atherosclerosis, Hypertension, and obesity in the Young (AHOY) of the Council on cardiovascular disease in young. American Heart Association. Circulation. 2002;106:143-60.
46. Steinberger J, Daniels SR. Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity and Metabolism). Circulation. 2003;107:1448-53.
47. Goran MI, Gower BA. Relation between visceral fat and disease risk in children. Am J Clin Nutr. 1999;70:S149-56.
48. Kotchen JM, Kotchen TA, Guthrie GP, Cottrill DM, McKean HE. Correlates of adolescent blood pressure at five year follow-up. Hypertension. 1980;2:124-9.
49. McGill HC, McMahan CA, Herderick EE, Zieske AW, Malcom GT, Tracy RE, et al. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation. 2002;105:2712-8.
50. Becque MD, Katch VL, Rocchinni AP, Marks CR, Moorehead C. Coronary risk incidence of obese adolescents: reduction by exercise plus diet intervention. Pediatrics. 1988;81:605-12.
51. Tracy R, Newman WP 3rd, Wattihney WA, Berenson GS. Risk factors and atherosclerosis in youth autopsy findings of the Bogalusa Heart Study. Am J Med Sci. 1995;310 Suppl 1:S37-41.
52. Ferguson MA, Gutin B, Owens S, Litaker M, Tracy RP, Allison J. Fat distribution and hemostatic measures in obese children. Am J Clin Nutr. 1998;67:1136-40.
53. Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hipertensión Control in Children and Adolescents. Pediatrics. 1996;98:649-58.
54. Sorof J, Daniels S. Obesity hypertension in children: a problem of epidemic proportions. Hypertension. 2002;40:441-7.
55. Sinaiko AR, Steinberger J, Moran AM, Prineas RJ, Jacobs DR Jr. Relation of insulin resistance to blood pressure in childhood. J Hypertens. 2002;20:509-17.
56. Kohen-Avramoglu R, Theriault A, Adeli K. Emergence of the metabolic syndrome in childhood: an epidemiological overview and mechanistic link to dyslipemia. Clinical Biochemistry. 2003;36:413-20.
57. Srinivasan SR, Myers M, Berenson GS. Predictability of childhood adiposity and insulin for developing insulin resistance syndrome in young adulthood: the Bogalusa Heart Study. Diabetes. 2002;51:204-9.
58. Arslanian S, Suprasongsin C. Insulin sensitivity, lipids and body composition in childhood: is "syndrome X" present? J Clin Endocrinol Metab. 1996;81:1058-62.
59. Einhorm D. American College of Endocrinology Position Statement on the insulin resistant syndrome. Endocr Pract. 2003;9 Suppl 2:7-19.